JFB prioritizes structured metadata and DOI registration so fertility biomarker research is discoverable across scholarly platforms. Indexing helps evidence reach clinicians, embryologists, and policy leaders who rely on validated data.

Our production workflow includes metadata validation and citation checks to improve discoverability and long term accuracy.

JFB maintains core identifiers and metadata services that support reliable citation, cataloging, and discovery across platforms.

• ISSN registration for consistent journal identification
• DOI assignment and metadata registration via Crossref
• Google Scholar discoverability subject to inclusion and crawling guidelines

• Accurate author names, affiliations, and ORCID identifiers
• Funding sources, grant numbers, and conflict disclosures
• Structured abstracts with clear objectives and results
• Fertility biomarker keywords and assay descriptors
• Complete references with DOIs where available

Authors help improve discoverability by providing complete metadata, accurate references, and clear funding statements. Well structured abstracts and keywords improve visibility for fertility and reproductive medicine audiences.

• Include ORCID identifiers where available
• Use standardized biomarker terminology
• Provide data repository links and accession numbers
• Ensure citations match reference lists
• Provide ORCID identifiers for all authors to strengthen metadata matching.
• Use standardized fertility biomarker keywords and relevant MeSH terms.
• Include funding agency names and grant numbers for metadata completeness.
• Ensure author affiliations include institution names and country information.
• Confirm DOI links are accurate and resolve correctly.
• Ensure references include year, volume, issue, and page ranges.
• Provide corresponding author email for indexing contact.
• Use structured abstracts with clear objectives and outcomes.
• Include biomarker type and assay keywords to improve discoverability.
• Ensure article titles are descriptive and avoid unexplained acronyms.
• List data repository citations separately when required.
• Check that supplementary files are referenced in metadata.
• Use consistent author name formatting across manuscript and metadata.
• Provide trial registration identifiers when applicable.
• Confirm funding acknowledgements are consistent across files.
• Include clinical setting or cohort descriptors when relevant.
• Ensure measurement units and abbreviations are standardized.
• Provide version numbers for datasets when citing database releases.
• Include reproductive stage or diagnosis keywords for targeted indexing.
• Provide biomarker or assay terms in keywords when relevant.

Indexing updates: Coverage can vary by platform and may update over time. If you need verification for a specific database or reporting requirement, contact [email protected].

JFB is committed to rigorous, transparent publishing in fertility biomarker research and reproductive medicine. We emphasize reproducible laboratory methods, clear reporting of diagnostic criteria, and ethical compliance across all article types.

The editorial office supports authors, editors, and reviewers with clear guidance and responsive communication. For questions about scope or workflow, contact [email protected].

We encourage continuous improvement in reporting practices and share updates that help the community maintain high standards in biomarker validation, reproductive outcomes, and translational fertility science.